Latest News

  • Verily, Samsung Collaboration, PathAI Receives FDA Approval, LinusBio Expands Test Further

    Diagnostics World | Verily Life Sciences and Samsung Electronics America enter a collaboration; PathAI announces that the U.S. Food and Drug Administration has granted Breakthrough Device Designation to PathAssist Derm; LinusBio announces that ClearStrand-ASD is now available for children up to age 10; and more.

    Mar 24, 2026

  • Beyond the Breakthrough: What Alzheimer’s Blood Tests Need Before They Can Truly Change Care

    Diagnostics World | The gold standard tests — PET scans that visualize amyloid plaques and cerebral spinal fluid (CSF) assays that measure core biomarkers directly — have long been the backbone of accurate Alzheimer’s diagnoses. Next-generation Alzheimer’s blood-based biomarkers are now producing accuracy levels in the greater than 90% sensitivity range, roughly on par with PET and CSF. This is not just a scientific milestone — it feels like a shift in what is possible for everyday clinical practice.

    Mar 20, 2026

  • Illumina, Labcorp Expand Collaboration, Develop New IVD Tests

    Diagnostics World | Illumina and Labcorp today announced an expanded collaboration to develop applications of next-generation sequencing (NGS) solutions across the healthcare ecosystem. Projects are expected to include distributed cancer biomarker test offerings; generating evidence to facilitate payer coverage; and developing new tests to address areas of unmet need.

    Mar 18, 2026

  • Simple Blood Test Predicts Survival Based on Causal Biomarkers

    Diagnostics World | Aging has increasingly been viewed as a modifiable target for therapeutic intervention, an encouraging idea that was recently reaffirmed with the development of a simple blood test for predicting survival. The biomarkers being measured include five piwi-interacting RNAs, together with high density lipoprotein particle number and the ability to do instrumental activities of daily living, such as the ability to independently shop and do housework.

    Mar 17, 2026

  • Droplet Biosciences Turns Post-Op Waste Into Life-Saving Data

    Diagnostics World |Droplet Bioscience’s validated clinical test analyzes post-surgical lymphatic fluid for circulating tumor DNA. In a process sped up by NVIDIA Parabricks, the test can provide adjuvant-informing results in about a week.

    Mar 11, 2026

  • The GLP-1 Era: It’s More Than Just Weight

    Diagnostics World News | The healthcare industry has a weight problem—a weight bias problem, according to Ashley Koff, RD, founder of The Better Nutrition Program. During her plenary keynote at February’s Integrative Healthcare Symposium, Koff addressed the urgent need to rethink approaches to weight, metabolic health, and the use of GLP-1 medications.

    Mar 10, 2026

  • Rethinking Long COVID: Targeting Root Causes First

    Diagnostics World News | At February’s Integrative Healthcare Symposium, Dr. George Schatz urged clinicians to rethink how they evaluate long COVID. For patients who still struggle with long-term fatigue, brain fog, palpitations, and sleep disruption, he proposed a diagnostics-first framework that prioritizes mechanism over labels.

    Mar 5, 2026

  • Blood Test Suggests if Gallstones Could Progress to Cancer

    Diagnostics World News | The vast number and diversity of chemicals that exist in the natural world represent both the cause of and solution to all the world’s problems. As such, they are foundational, high-stakes agents irrespective of the biological system—be they comprised of plants, microorganisms, or human beings.

    Mar 4, 2026

  • Epigenetic Instability Metric Could Aid Early Cancer Detection Efforts

    Diagnostics World News | The quest to marry different DNA methylation technologies for the purpose of early cancer detection has been ongoing for several decades now. Among the recent breakthroughs is an “epigenetic instability index” (EII) measuring the randomness of methylation rather than just consistent, fixed changes.

    Mar 3, 2026

  • Sanofi’s New CEO, PacBio, iHope Collaboration, Astoriom Further Expands in North America

    Diagnostics World News | Sanofi appoints Belén Garijo as chief executive officer; PacBio collaborates with iHope; Astoriom acquires Precision Stability Storage, expanding its sample management capabilities in the U.S.; and more.

    Feb 26, 2026

  • Follow the Money: Personalized Therapy for Colorectal Cancer, Methyl-Copying PCR Platform, More

    Diagnostics World News | Neogap Therapeutics advances their ongoing clinical study for personalized therapy for advanced colorectal cancer; Syndex Bio introduced its proprietary mcPCR (methyl-copying PCR) platform; and more.

    Feb 25, 2026

  • Precision Medicine Needs Precision Engineered Diagnostic Systems

    Diagnostics World News | Precision medicine is often described as the future of healthcare. But from an engineering standpoint, it’s already here, and it’s forcing diagnostic instruments to evolve faster than most development cycles are comfortable with. We’re asking instruments to do more than confirm a suspected diagnosis. We’re asking them to deliver specificity, speed, and confidence in environments that aren’t always predictable. That’s a major shift from the days when “good enough” screening could drive clinical decisions.

    Feb 20, 2026

  • Clock Model Predicts When Alzheimer’s Symptoms Will Appear

    Diagnostics World News | Researchers from the Foundation for the National Institutes of Health (FNIH), Washington University in St. Louis, the University of California San Francisco, the University of Wisconsin-Madison, and more have published results of a study using a single plasma biomarker sample to estimate not only the probability of an Alzheimer’s Disease diagnosis, but when symptoms will develop.

    Feb 19, 2026

  • PacBio’s Rare Disease, ASO Push

    Diagnostics World News | PacBio has announced several rare disease genomics programs so far this year. The most recent partner organizations include iHope, N-Lorem, EspeRare, UW Medicine, and Seattle Children’s Hospital.

    Feb 17, 2026

  • Zentropy: A New Framework to Transform Medical Prediction

    Diagnostics World News | A research team at Penn State is reshaping the future of diagnostics by embedding the laws of thermodynamics directly into artificial intelligence (AI). Their framework, called zentropy-embedded neural networks (ZENN) promises to improve how clinicians interpret complex, multi-source diagnostic data, from brain scans to blood tests.

    Feb 13, 2026

  • UK Consortium Builds Cancer Dataset and AI Models with 10x Xenium Spatial Platform

    Diagnostics World News | PharosAI, a research consortium of four UK institutions, plans to use the 10x Genomics Xenium spatial platform to build one of the world's most comprehensive multimodal cancer datasets and pair them with advanced AI models and analytical capabilities. They plan to democratize access to these datasets, ensuring they are securely available to a broad community of researchers and innovators.

    Feb 6, 2026

  • Parkinson’s Disease Can Now Be Identified in Blood

    Diagnostics World News | No cure or established early-stage detection method for Parkinson's disease has been found yet. Patients do not receive a diagnosis until motor symptoms begin to appear. A team of researchers from Chalmers University of Technology, Sweden and Oslo University Hospital, Norway have found a way to identify early signs of Parkinson’s disease in the blood.

    Feb 5, 2026

  • Study Suggests ‘Brain is to Blame’ for High Blood Pressure

    Diagnostics World News | Soley Therapeutics will advance its proprietary cell stress sensing platform; Precede Biosciences’s platform aims to meet rapidly growing demand from developers of next-generation precision medicines; Proxima will accelerate the advancement of first-in-class proximity-modulating therapeutics; and more.

    Feb 3, 2026

  • Follow the Money: Cell Stress Sensing Platform, Next-Gen Precision Diagnostics Platform, Novel Proximity-Modulating Therapeutics

    Diagnostics World News | Soley Therapeutics will advance its proprietary cell stress sensing platform; Precede Biosciences’s platform aims to meet rapidly growing demand from developers of next-generation precision medicines; Proxima will accelerate the advancement of first-in-class proximity-modulating therapeutics; and more.

    Jan 28, 2026

  • Autism Early Risk Identifier, Increased Demand for Molecular Testing, Collaboration for Colorectal Cancer Detection

    Diagnostics World News | NeuroQure has launched ASD Insight, a first-of-its-kind test designed to identify autism risk as early as birth; Cytespace expanded its molecular testing to meet increasing demands across Sub-Saharan Africa; Daisy Genomics and New Day Diagnostics have entered a collaboration with the University of Tennessee and the East Tennessee Health Innovation Alliance; and more.

    Jan 27, 2026